Back to Top Skip to main content

DoD, FDA working together to benefit warfighters

Dr. Scott Gottlieb, FDA Commissioner (left) and Mr. Thomas McCaffery, Principal Deputy Assistant Secretary of Defense (Health Affairs) (right), congratulate on another following the signing of a memorandum of understanding between the DoD and the FDA.  The ceremony acknowledges the existing partnership and the future collaboration on accessing life-saving medical products for U.S. troops on the battlefield. Dr. Scott Gottlieb, FDA Commissioner (left) and Mr. Thomas McCaffery, Principal Deputy Assistant Secretary of Defense (Health Affairs) (right), congratulate one another following the signing of a memorandum of understanding between the DoD and the FDA. The ceremony acknowledges the existing partnership and the future collaboration on accessing life-saving medical products for U.S. troops on the battlefield.

Recommended Content:

Health Readiness

In a move to better serve the unique needs of the nation’s warfighters, leaders from the U.S. Food and Drug Administration and the Office of the Assistant Secretary of Defense for Health Affairs signed a memorandum of understanding to foster and prioritize the development of critical medical products.

The signing of the memorandum formalizes the partnership between the FDA and the Department of Defense that was authorized under a law enacted by Congress in 2017. Under this law, DoD is able to request help in speeding up development and review of products used to diagnose, treat, or prevent serious or life-threatening diseases and conditions faced by service members. It also allows for emergency use of medical products for threats that pose a specific risk to service members, including biological, chemical, radiological, or nuclear agents.

The FDA will continue to work with DoD to evaluate how to best access medical products that serve the military’s medical needs and rush review of priority DoD medical products. The FDA will also provide advice for the development and manufacturing of these products, and examine those that are already under development to determine which will streamline review.

The memorandum directs specific actions between the agencies, including semi-annual meetings at the senior-leader levels, quarterly meetings with FDA centers, and collaborations on emergency use of products.

Dr. Terry Rauch, acting deputy assistant secretary of Defense for Health Readiness Policy and Oversight, said the memorandum enables the Military Health System to speak through one voice with the FDA on strategic issues and to move forward on urgent needs with a prioritized DoD list for the FDA to focus on.

“DoD and FDA have always been committed to safe and effective products for our service members, and this [memorandum] really solidifies the needed relationship to provide these most effectively,” said Rauch. “We have already seen increased readiness due to the collaborative efforts with the approval of three medical products since the release of the law.”

The FDA has approved the use of an auto-injector for nerve agent exposure, a prophylactic drug for malaria, and the RECELL system for point-of-care skin regeneration in trauma patients. These products were approved after the release of the law, and the memorandum strengthens these efforts even further, he said.

“These products are critical to warfighter readiness in deployed environments and to the far-forward care settings that we face,” said Rauch. “Battlefield trauma and prolonged field care are at the forefront of challenges in military medicine.”

Earlier this year, the FDA granted emergency use authorization for DoD’s use of freeze-dried plasma. Rauch described it as a life-saving product designed for austere environments, which can now be used in a much more streamlined process under the authorization. In addition, the FDA approved a new malaria prophylactic drug, tafenoquine, in August.

“The FDA has been incredibly helpful and forward-leaning with all aspects of interaction on DoD medical product development,” said Rauch. “We are grateful that there is an increased interest by the leadership to drive collaboration, and we are leveraging that interest to the fullest.”

You also may be interested in...

Health Services Headquarters Marine Corps

Presentation
8/10/2017

Defense Health Board briefing about the Health Services Headquarters Marine Corps

Recommended Content:

Health Readiness

United States Transportation Command

Presentation
8/10/2017

Defense Health Briefing about the United States Transportation Command

Recommended Content:

Health Readiness

Overview of Navy Medicine

Presentation
2/9/2017

Recommended Content:

Health Readiness | Military Medical History

Tasking Update Pediatric Health Care Services

Presentation
2/9/2017

Tasking Update: Pediatric Health Care Services

Recommended Content:

Health Readiness | Access, Cost, Quality, and Safety

Deployment Health Centers Review

Presentation
11/1/2016

Deployment Health Centers Review briefing to the Defense Health Board, Nov. 1, 2016.

Recommended Content:

Health Readiness

A National Trauma Care System

Presentation
8/9/2016

A National Trauma Care System: Integrating Military and Civilian Trauma Systems to Achieve Zero Preventable Deaths After Injury

Recommended Content:

Health Readiness | Research and Innovation | Access, Cost, Quality, and Safety

59th Medical Wing Mission and Initiatives

Presentation
8/9/2016

Recommended Content:

Health Readiness

Reconstruction and Restoration of the Genitourinary System after Contemporary Battlefield Urotrauma

Presentation
8/9/2016

Recommended Content:

Conditions and Treatments | Health Readiness

Review of the Defense Health Board’s Combat Trauma Lessons Learned from Military Operations of 2001-2013 Report

Presentation
8/9/2016

The in-depth information and recommendations in the report enable [the Office of the Assistant Secretary of Defense for Health Affairs] to consider approaches to enhance Combat Casualty Care.

Recommended Content:

Conditions and Treatments | Research and Innovation | Health Readiness

Infectious Disease Clinical Research Program

Presentation
6/2/2016

Recommended Content:

Health Readiness

Health Care Delivery Subcommittee Tasking Update Pediatric Clinical Preventive Services

Presentation
6/2/2016

Health Care Delivery Subcommittee Tasking Update: Pediatric Clinical Preventive Services

Recommended Content:

Health Readiness

Defense Advanced Research Projects Agency DARPA Biological Technologies Office BTO Overview

Presentation
6/2/2016

Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) Overview

Recommended Content:

Health Readiness

Study to Assess Risk and Resilience in Servicemembers

Presentation
6/2/2016

Recommended Content:

Health Readiness

Decision Brief on Ethical Guidelines and Practices for U.S. Military Medical Professionals

Presentation
2/11/2015

Decision Brief on Ethical Guidelines and Practices for U.S. Military Medical Professionals presented to the Defense Health Board

Recommended Content:

Health Readiness

Advances in Trauma Resuscitation

Presentation
8/11/2014

Recommended Content:

Conditions and Treatments | Health Readiness
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.